Last update 08 Mar 2025

ALK-SCHERAX Arzneimittel GmbH

Subsidiary Company|
Germany
|
www.alk-scherax.de

Overview

Related

2
Clinical Trials associated with ALK-SCHERAX Arzneimittel GmbH
EUCTR2007-000921-23-DE
/ Not yet recruitingNot Applicable
A randomised, parallel-group, double-blind, placebo-controlled, multicentre Phase III trial assessing the pharmacodynamic efficacy and safety of an intraseasonal short-time updosing schedule for Alutard SQ - Intraseasonal short-time updosing for Alutard SQ
EUCTR2005-004675-37-DE
/ Not yet recruitingNot Applicable
Multicenter, randomized, double-blind, placebo-controlled parallel group study to demonstrate the efficacy of a 12-month subcutaneous specific immunotherapy with ALK-depot SQ Milbenmischung in patients with atopic dermatitis and proven IgE-mediated sensitization to house dust mites - ALK-depot SQ AD Study
100 Clinical Results associated with ALK-SCHERAX Arzneimittel GmbH
Login to view more data
0 Patents (Medical) associated with ALK-SCHERAX Arzneimittel GmbH
Login to view more data
100 Deals associated with ALK-SCHERAX Arzneimittel GmbH
Login to view more data
100 Translational Medicine associated with ALK-SCHERAX Arzneimittel GmbH
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 30 Apr 2025

No data posted
Login to keep update

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free